Skip to main content
STRIDES PHARMA SCIENCE LIMITED logo

STRIDES PHARMA SCIENCE LIMITED — Investor Relations & Filings

Ticker · STAR ISIN · INE939A01011 LEI · 335800WHFYXUCHR9DD10 BSE.NS Manufacturing
Open in API
Filings indexed 1,200 across all filing types
Latest filing 2022-06-18 Major Shareholding Noti…
Country IN India
Listing BSE.NS STAR

About STRIDES PHARMA SCIENCE LIMITED

https://www.strides.com

Strides Pharma Science Limited is a global pharmaceutical organization focused on the development and manufacture of IP-led niche finished dosage formulations. The company’s product portfolio encompasses a wide range of therapeutic areas, specializing in complex oral solids, softgel capsules, topicals, and liquids. It maintains a significant presence in highly regulated markets, including the United States, Europe, and Australia, while also serving institutional and emerging markets. The company operates multiple manufacturing facilities globally, many of which are approved by major international regulatory agencies such as the USFDA. Strides emphasizes research and development to drive innovation in specialized delivery systems and difficult-to-manufacture products, positioning itself as a key player in the global generic pharmaceutical landscape.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document text contains detailed information about promoter holdings, creation and release of encumbrances, and shareholding percentages related to a company. It references SEBI regulations on substantial acquisition of shares and takeovers (SAST Regulations). The content is focused on changes in significant share ownership levels and disclosures related to promoter holdings. There is no indication of financial statements, management discussion, or report publication. The document is a notification of changes in major shareholding levels, consistent with the definition of Major Shareholding Notification (MRQ). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS.
2022-06-18 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document contains detailed information about encumbrance events related to shares, including percentages of total equity share capital, promoter holdings, and specific dates and types of encumbrance events such as invocation. It references SEBI regulations related to substantial acquisition of shares and takeovers, indicating it is a regulatory disclosure about share encumbrance. The content is focused on shareholding and encumbrance details rather than financial results, management changes, or meeting materials. Given the nature of the data and the regulatory context, this fits best under Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership or related disclosures under takeover regulations.
2022-06-18 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document contains detailed data about shareholding percentages, promoter holdings, and encumbrance events related to shares. It references SEBI regulations on substantial acquisition of shares and takeovers, indicating it is a regulatory disclosure about shareholding changes or encumbrance events. The content is focused on shareholding details and regulatory compliance disclosures rather than financial results, management changes, or meeting materials. Given the nature of the data and the reference to SEBI SAST regulations, this fits best under Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels or encumbrances.
2022-06-18 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document contains detailed data on shareholding percentages, promoter holdings, encumbrance events, and references to SEBI regulations related to substantial acquisition of shares and takeovers. It includes numeric data on shares and percentages, dates of creation and release of encumbrances, and names of promoters. The content is focused on shareholding disclosures and encumbrance events rather than financial results, management changes, or meeting materials. The presence of SEBI (Securities and Exchange Board of India) regulations and the nature of the data indicate this is a notification related to major shareholding or changes in share ownership levels. The document length is short (2217 characters) and contains detailed shareholding data, not just an announcement or a certification. Therefore, the best fitting category is Major Shareholding Notification (MRQ).
2022-06-18 English
Loss of share certificate
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges regarding a shareholder's request for issuance of a duplicate share certificate due to loss of the original. It references SEBI regulations and includes details of the shareholder and share certificate. The content is an official announcement about a share certificate issue, not a financial report, earnings release, or management discussion. It does not contain financial statements or analysis, nor is it a report publication announcement. The document fits the category of a Regulatory Filing (RNS) as it is a compliance-related announcement under SEBI regulations without fitting other specific categories.
2022-06-17 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Stelis Biopharma's two biologics manufacturing facilities have received EU cGMP accreditation. It contains no financial statements, no detailed financial performance data, no regulatory certifications or attestations, and no mention of shareholder votes or management changes. The document is a corporate announcement about a regulatory approval related to manufacturing facilities. It is not an annual report, interim report, earnings release, or any other detailed financial or governance report. The document is a press release, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-06-16 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.